SABS
SAB Biotherapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
USD3.92
+0.02 (+0.51%)
Rating:B-
Company Profile
CEO
Samuel J. Reich
IPO Date
2021-02-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Market Metrics
Open
$3.90
Prev. Close
$3.90
Day Low
$3.88
Day High
$3.98
52W Low
$1.70
52W High
$6.60
Market Cap
$0.04B
Volume
0.16M